title: Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.
authors: Giulia
authors: G
authors: Cervetti
authors: Sara
authors: S
authors: Galimberti
authors: Francesca
authors: F
authors: Andreazzoli
authors: Rita
authors: R
authors: Fazzi
authors: Nadia
authors: N
authors: Cecconi
authors: Francesco
authors: F
authors: Caracciolo
authors: Mario
authors: M
authors: Petrini
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab